Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-06-18 Purchase |
2020-06-23 9:21 pm |
Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO |
2,950 | $28 | $82,600 | 797,705 (Indirect Direct) |
View |
| 2020-06-18 Purchase |
2020-06-23 9:14 pm |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
15,000 | $28 | $420,000 | 1,556,624 (Indirect Direct) |
View |
| 2020-06-18 Purchase |
2020-06-23 9:13 pm |
Royalty Pharma plc | RPRX | Hite Christopher EVP & Vice Chairman |
70,000 | $28 | $1,960,000 | 248,600 (Direct) |
View |
| 2020-06-18 Purchase |
2020-06-22 9:55 pm |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner |
20,000 | $28 | $560,000 | 7,885,433 (Indirect) |
View |
| 2020-06-18 Purchase |
2020-06-22 9:55 pm |
Royalty Pharma plc | RPRX | FORD WILLIAM E Director |
1,500,000 | $28 | $42,000,000 | 4,414,862 (Indirect) |
View |
| 2020-06-18 Purchase |
2020-06-22 9:54 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
14,200 | $28 | $397,600 | 1,348,411 (Indirect Direct) |
View |
| 2020-06-18 Purchase |
2020-06-22 9:47 pm |
Royalty Pharma plc | RPRX | Giuliani Mario Germano Skyeline Management Ltd Avara Management Ltd Nogra Group SICAF SIF MGG Strategic Nogra Group SICAF SIF GG Strategic Director 10% Owner |
50,000 | $28 | $1,400,000 | 1,812,389 (Indirect) |
View |
| 2020-06-18 Purchase |
2020-06-22 5:31 pm |
Royalty Pharma plc | RPRX | ADAGE CAPITAL PARTNERS GP L.L.C. Adage Capital Partners L.P. Adage Capital Advisors L.L.C. Atchinson Robert Gross Phillip 10% Owner |
3,000,000 | $28 | $84,000,000 | 46,350,843 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-09-30 Option Award |
2020-10-02 7:08 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Engelbert Catherine M. Director |
910 | $41.17 | 13,410 (Direct) |
View |
| 2020-09-30 Option Award |
2020-10-02 7:07 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Bassler Bonnie L Director |
910 | $41.17 | 13,547 (Direct) |
View |
| 2020-06-15 Option Award |
2020-09-23 8:30 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Norden Gregory Director |
24,523 | $0 | 60,238 (Direct) |
View |
| 2020-06-18 Option Award |
2020-09-23 8:29 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Engelbert Catherine M. Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2020-06-15 Option Award |
2020-09-23 8:28 pm |
N/A N/A |
Royalty Pharma plc | RPRX | DESOUZA ERROL B Director |
62,844 | $0 | 98,559 (Indirect) |
View |
| 2020-06-18 Option Award |
2020-09-23 8:26 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Bassler Bonnie L Director |
12,500 | $0 | 12,637 (Direct) |
View |
| 2020-06-30 Option Award |
2020-09-23 8:26 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Bassler Bonnie L Director |
137 | $48 | 12,637 (Direct) |
View |
| 2020-08-13 Option Award |
2020-08-17 8:42 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
7,280 | $0 | 7,280 (Direct) |
View |
| 2020-08-13 Option Award |
2020-08-17 8:40 pm |
N/A N/A |
Royalty Pharma plc | RPRX | LOVE TED W Director |
7,280 | $0 | 17,280 (Direct) |
View |
Ownership |
2020-08-10 9:56 pm |
N/A N/A |
Royalty Pharma plc | RPRX | LOVE TED W Director |
0 | $0 | 10,000 (Direct) |
View |
Ownership |
2020-08-10 9:27 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
0 | $0 | 419,480 (Direct) |
View |
| 2020-06-15 Option Award |
2020-06-23 9:21 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO |
772,754 | $0 | 797,705 (Indirect) |
View |
| 2020-06-18 Conversion |
2020-06-23 9:21 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO |
25,597 | $0 | 797,705 (Indirect) |
View |
| 2020-06-15 Option Award |
2020-06-23 9:14 pm |
N/A N/A |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
1,541,624 | $0 | 1,556,624 (Direct) |
View |
| 2020-06-15 Option Award |
2020-06-23 9:13 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Hite Christopher EVP & Vice Chairman |
178,600 | $0 | 248,600 (Direct) |
View |
| 2020-06-15 Option Award |
2020-06-22 9:56 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments |
863,283 | $0 | 888,508 (Indirect) |
View |
| 2020-06-18 Conversion |
2020-06-22 9:56 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments |
27,533 | $0 | 888,508 (Indirect) |
View |
| 2020-06-15 Option Award |
2020-06-22 9:55 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner |
7,765,047 | $0 | 7,885,433 (Indirect) |
View |
| 2020-06-18 Conversion |
2020-06-22 9:55 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner |
265,991 | $0 | 7,885,433 (Indirect) |
View |
| 2020-06-15 Option Award |
2020-06-22 9:55 pm |
N/A N/A |
Royalty Pharma plc | RPRX | FORD WILLIAM E Director |
2,914,862 | $0 | 4,414,862 (Indirect) |
View |
| 2020-06-15 Option Award |
2020-06-22 9:54 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
1,069,401 | $0 | 1,348,411 (Direct) |
View |
| 2020-06-18 Conversion |
2020-06-22 9:54 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
289,036 | $0 | 1,348,411 (Indirect) |
View |
| 2020-06-15 Option Award |
2020-06-22 9:47 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Giuliani Mario Germano Skyeline Management Ltd Avara Management Ltd Nogra Group SICAF SIF MGG Strategic Nogra Group SICAF SIF GG Strategic Director 10% Owner |
1,328,298 | $0 | 1,812,389 (Indirect) |
View |
| 2020-06-18 Conversion |
2020-06-22 9:47 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Giuliani Mario Germano Skyeline Management Ltd Avara Management Ltd Nogra Group SICAF SIF MGG Strategic Nogra Group SICAF SIF GG Strategic Director 10% Owner |
64,758,912 | $0 | 1,812,389 (Indirect) |
View |
| 2020-06-18 Conversion |
2020-06-22 5:31 pm |
N/A N/A |
Royalty Pharma plc | RPRX | ADAGE CAPITAL PARTNERS GP L.L.C. Adage Capital Partners L.P. Adage Capital Advisors L.L.C. Atchinson Robert Gross Phillip 10% Owner |
47,652,376 | $0 | 46,350,843 (Indirect) |
View |
| 2020-06-15 Option Award |
2020-06-17 9:49 pm |
N/A N/A |
Royalty Pharma plc | RPRX | DESOUZA ERROL B Director |
35,715 | $0 | 35,715 (Direct) |
View |
| 2020-06-15 Option Award |
2020-06-17 9:49 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Norden Gregory Director |
35,715 | $0 | 35,715 (Direct) |
View |
Ownership(A) |
2020-06-17 8:51 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO |
0 | $0 | 48,000 (Direct) |
View |
Ownership |
2020-06-15 9:56 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Giuliani Mario Germano Skyeline Management Ltd Avara Management Ltd Nogra Group SICAF SIF MGG Strategic Nogra Group SICAF SIF GG Strategic Nogra Group SICAF - SIF S.A. Severgnini Achille G. Director 10% Owner |
0 | $0 | 63,211,740 (Indirect) |
View |
Ownership |
2020-06-15 9:56 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board |
0 | $0 | 62,552,304 (Indirect) |
View |
Ownership |
2020-06-15 9:47 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Hite Christopher EVP & Vice Chairman |
0 | $0 | 741,100 (Direct) |
View |
Ownership |
2020-06-15 9:43 pm |
N/A N/A |
Royalty Pharma plc | RPRX | FORD WILLIAM E Director |
0 | $0 | 29,148,620 (Indirect) |
View |
Ownership |
2020-06-15 9:36 pm |
N/A N/A |
Royalty Pharma plc | RPRX | ADAGE CAPITAL PARTNERS GP L.L.C. Adage Capital Partners L.P. Adage Capital Advisors L.L.C. Atchinson Robert Gross Phillip 10% Owner |
0 | $0 | 46,370,460 (Indirect) |
View |
Ownership |
2020-06-15 9:27 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO |
0 | $0 | 4,502,540 (Indirect) |
View |
Ownership |
2020-06-15 9:27 pm |
N/A N/A |
Royalty Pharma plc | RPRX | DESOUZA ERROL B Director |
0 | $0 | 539,150 (Indirect) |
View |
Ownership |
2020-06-15 9:26 pm |
N/A N/A |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
0 | $0 | 15,416,240 (Direct) |
View |
Ownership |
2020-06-15 9:25 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments |
0 | $0 | 6,832,830 (Indirect) |
View |
Ownership |
2020-06-15 9:24 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Norden Gregory Director |
0 | $0 | 155,940 (Direct) |
View |
Ownership |
2020-06-15 9:20 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
0 | $0 | 7,517,010 (Direct) |
View |